BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 13678633)

  • 1. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
    Dalton JP; Neill SO; Stack C; Collins P; Walshe A; Sekiya M; Doyle S; Mulcahy G; Hoyle D; Khaznadji E; Moiré N; Brennan G; Mousley A; Kreshchenko N; Maule AG; Donnelly SM
    Int J Parasitol; 2003 Sep; 33(11):1173-81. PubMed ID: 13678633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
    Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
    Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
    Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
    Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
    Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
    Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin.
    Dalton JP; McGonigle S; Rolph TP; Andrews SJ
    Infect Immun; 1996 Dec; 64(12):5066-74. PubMed ID: 8945548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle.
    Cornelissen JB; Gaasenbeek CP; Boersma W; Borgsteede FH; van Milligen FJ
    Int J Parasitol; 1999 May; 29(5):685-96. PubMed ID: 10404262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
    Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
    Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
    Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
    Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease.
    Cornelissen JB; Gaasenbeek CP; Borgsteede FH; Holland WG; Harmsen MM; Boersma WJ
    Int J Parasitol; 2001 May; 31(7):728-37. PubMed ID: 11336755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the antibody response to adult Fasciola hepatica excretory/secretory products in experimentally and naturally infected cattle and sheep.
    Walsh TR; Ainsworth S; Armstrong S; Hodgkinson J; Williams D
    Vet Parasitol; 2021 Jan; 289():109321. PubMed ID: 33276290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological approaches for the control of fasciolosis.
    Spithill TW; Piedrafita D; Smooker PM
    Int J Parasitol; 1997 Oct; 27(10):1221-35. PubMed ID: 9394193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1).
    Golden O; Flynn RJ; Read C; Sekiya M; Donnelly SM; Stack C; Dalton JP; Mulcahy G
    Vaccine; 2010 Aug; 28(34):5551-7. PubMed ID: 20600503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
    Mezo M; González-Warleta M; Carro C; Ubeira FM
    J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice.
    Smooker PM; Kennedy NJ; Steeper KR; Christopoulos H; Spithill TW
    Exp Parasitol; 2001 Mar; 97(3):154-60. PubMed ID: 11312577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.